Ovarian Cancer

>

Latest News

ovarian cancer
Olaparib Misses Mark in Recurrent Platinum-Sensitive Ovarian Cancer

November 25th 2023

Olaparib did not significantly improve overall survival compared with chemotherapy in recurrent, platinum-sensitive ovarian cancer.

gynecologic cancer
Final OVHIPEC-1 Analysis Supports HIPEC with Interval Cytoreductive Surgery in Stage III Ovarian Cancer

October 10th 2023

Ponatinib Shows Promise for Rare Ovarian Cancer Type that Affects Young Women
Ponatinib Shows Promise for Rare Ovarian Cancer Type that Affects Young Women

March 8th 2018

© 2023 MJH Life Sciences

All rights reserved.